Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...

Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene therapy expertise, today announced the significant expansion of its gene therapy platform.

We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...

STRM.BIO, a biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today ...

GenScript is delighted to announce its 4th Annual Virtual Summit on Gene and Cell Engineering. This event will feature leading experts from academia, pharma, and biotech, showcasing the transformative ...

NSF CAREER award recipient Tomas Gonzalez-Fernandez, an assistant professor of bioengineering in Lehigh University’s P.C. Rossin College of Engineering and Applied Science, leads research at the ...

Current gene therapies to treat sickle cell disease are complex, time-consuming, and are sometimes linked to serious side effects like infertility or blood cancer. To address these challenges, Johns ...

At a meeting of top conservation groups this week, a bioethics question took center stage: Should scientists be allowed to tinker with the genes of wild plants and animals? The tentative consensus so ...

Earth's biodiversity is in crisis. An imminent "sixth mass extinction" threatens beloved and important wildlife. It also threatens to reduce the amount of genetic diversity—or variation—within species ...

Canada is wrestling with how gene-editing should translate to voluntary genetically modified food labels, or whether it even ...